Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis

BACKGROUND: Patients with coronavirus disease 2019 (COVID-19) infections often have macrovascular or microvascular thrombosis and inflammation, which are known to be associated with a poor prognosis. Heparin has been hypothesized that administration of heparin with treatment dose rather than prophyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyeon-Jeong, Jang, Hye Jin, Choi, Won-Il, Joh, Joonsung, Kim, Junghyun, Park, Jungeun, Choi, Miyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Critical Care Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265420/
https://www.ncbi.nlm.nih.gov/pubmed/37313662
http://dx.doi.org/10.4266/acc.2022.01424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265420/
https://www.ncbi.nlm.nih.gov/pubmed/37313662
http://dx.doi.org/10.4266/acc.2022.01424

Ejemplares similares